A study of the metabolites of ischemia-reperfusion injury and selected amino acids in the liver using microdialysis during transplantation

Transplantation

Volumn 79, Issue 7, 2005, Pages 828-835

  Silva, Michael A ^a,c   Richards, Douglas A ^b   Bramhall, Simon R ^a   Adams, David H ^a   Mirza, Darius F ^a   Murphy, Nick ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Arginase; Arginine; Nitric oxide; Nitric oxide synthase; Urea cycle

Indexed keywords

4 AMINOBUTYRIC ACID; ALANINE; AMINO ACID; ARGINASE; ARGININE; CITRULLINE; GLUTAMIC ACID; GLUTAMINE; GLYCEROL; GLYCINE; LACTIC ACID; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; ORNITHINE; PYRUVIC ACID; TAURINE;

ADULT; AMINO ACID BLOOD LEVEL; AMINO ACID TRANSPORT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DETOXIFICATION; FEMALE; GLYCEROL BLOOD LEVEL; HUMAN; ISCHEMIA; LIVER CELL; LIVER TRANSPLANTATION; MALE; MICRODIALYSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REPERFUSION INJURY; UREA CYCLE;

ADULT; AGED; AMINO ACIDS; CITRULLINE; FEMALE; GLUTAMINE; GLYCINE; HUMANS; LIVER; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MICRODIALYSIS; MIDDLE AGED; REPERFUSION INJURY;

EID: 17444423710     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000153156.38617.97     Document Type: Article

References (40)

1. Carini R, Albano E. Recent insights on the mechanisms of liver preconditioning. Gastroenterology 2003; 125(5): 1480.
2. Urena MAG, Gonzalez EM, Romero CJ, et al. An approach to the rational use of steatotic donor livers in liver transplantation. Hepatogastroenterology 1999; 46: 1164.
3. Gracia CE, Bramhall S, Mirza DF. Use of marginal donors. Curr Opin Organ Transplant 2000; 5: 50.
4. Selnzer M, Clavien PA. Hepatic steatosis and liver transplantation: Current clinical and experimental perspectives. Liver Dis 2001; 21: 105.
5. Nowak G, Ungerstedt J, Wernerman J, et al. Metabolic changes in the liver graft monitored continuously with microdialysis during liver transplantation in a pig model. Liver Transplant 2002; 8(5): 424.
6. Muller M. Microdialysis: Clinical review. BMJ 2002; 324: 588.
7. Benveniste H, Huttemeier PC. Microdialysis: Theory and application. Prog Neurobiol 1990; 35(195): 215.
8. Lönnroth P. Microdialysis: Theory and application. J Intern Med 1991; 230: 363.
9. Ungerstedt U. principles and applications for studies in animals and man. J Intern Med 1991; 230: 365.
10. Bolinder J, Ungerstedt U, Arner P. Long term continuous glucose monitoring with microdialysis in ambulatory insulin dependent diabetic patients. Lancet 1993; 342: 1080.
11. Nilsson OG, Brandt L, Ungerstedt U, et al. Bedside detection of brain ischemia using intracerebral microdialysis: Subarachnoid hemorrhage and delayed ischemic deterioration. Neurosurgery 1999; 45: 1176.
12. Richards DA, Tolias CM, Sgouros S, et al. Extracellular glutamine to glutamate ratio may predict outcome in the injured brain: A clinical microdialysis study in children. Pharmacol Res 2003; 48: 101.
13. Wu G, Morris SM. Arginine metabolism: Nitric oxide and beyond. Biochem J 1998; 336: 1.
14. Erlitzki R, Gong Y, Zhang M, et al. Identification of gamma-aminobutyric acid receptor subunit types in human and rat liver. Am J Physiol 2000; 279: G733.
15. Gill SS, Pulido OM. Glutamate receptors in peripheral tissues: Current knowledge, future research, and implications for toxicology. Toxicol Pathol 2001; 29: 208.
16. Wettstein M, Haussinger D. Taurine attenuates cold ischemia-reoxygenation injury in rat liver. Transplantation 2000; 69: 2290.
17. Gonzalez EM, Rimola A, Grande L, et al. Predictive factors of early postoperative graft function in human liver transplantation. Hepatology 1994; 20(3): 565.
18. Ploeg RJ, D'Alessandro AM, Knechtle SJ, et al. Malfunction of the liver after transplantation: An analysis of potential risk factors. Transplant Proc 1993; 25: 1659.
19. Plevris JN, Jalan R, Bzeizi KI, et al. Indocyanine green clearance reflects reperfusion injury following liver transplantation and is an early predictor of graft function. J Hepatol 1999; 30: 142.
20. Nowak G, Ungerstedt J, Wernerman J, et al. Clinical experience in continuous graft monitoring with microdialysis early after liver transplantation. Br J Surg 2002; 89: 1169.
21. Hillered L, Persson L. Neurochemical monitoring of the acutely injured human brain. Scand J Clin Invest 1999; 229 (Suppl): 9.
22. Sommer T, Larsen JF. Intraperitoneal and intraluminal microdialysis in the detection of experimental regional intestinal ischaemia. Br J Surg 2004; 91 (7): 855.
23. Chavez-Cartaya RE, Metcalf S, Ramirez-Romero P, et al. Rat liver blood flow after ischemia and reperfusion: The effects of the platelet-activating factor antagonist WEB-2170 and removing circulating leucocytes. Transplantation 1994; 57: 1440.
24. Klover PJ, Mooney RA. Hepatocytes: Critical for glucose homeostasis. Int J Biochem Cell Biol 2004; 36(5): 753.
25. Erdo SL, Wolff JR. Gamma-aminobutyric acid outside the mammalian brain. J Neurochem 1990; 54: 363.
26. Gill SS, Mueller RW, McGuire PF, et al. Potential target sites in peripheral tissues for excitatory neurotransmission and excitotoxicity. Toxicol Pathol 2000; 28: 277.
27. Warskulat U, Wettstein M, Haussinger D. Osmoregulated taurine transport in H411E hepatoma cells and perfused rat liver. Biochem J 1997; 321: 683.
28. Esteban FJ, Pedrosa JA, Jimenez A, et al. Distribution of neuronal nitric oxide synthase in the rat liver. Neurosci Lett 1997; 226: 99.
29. Shah V, Kamath PS. Nitric oxide in liver transplantation: Pathobiology and clinical implications. Liver Transpl 2003; 9: 1.
30. Isobe M, Katsuramaki T, Hirata K, et al. Beneficial effects of inducible nitric oxide synthase inhibitor on reperfusion injury in the pig liver. Transplantation 1999; 68: 803.
31. Kimura H, Katsuramaki T, Isobe M, et al. Role of inducible nitric oxide synthase in pig liver transplantation. J Surg Res 2003; 111: 28.
32. Yagnik GP, Takahashi Y, Tsoulfas G, et al. Blockade of the L-arginase/NO synthase pathway worsens hepatic apoptosis and liver transplant preservation injury. Hepatology 2002; 36(3): 573.
33. Inoue Y, Bode BP, Beck DJ, et al. Arginine transport in human liver: Characterization and effects of nitric oxide synthase inhibitors. Ann Surg 1993; 218: 350.
34. Hwang T-L, Yang JT, Lau Y-T. Arginine-nitric oxide pathway in plasma membrane of rat hepatocytes during early and late sepsis. Crit Care Med 1999; 27: 137.
35. Souba WW. Hepatic arginine metabolism: Major questions remain unanswered. Crit Care Med 1999; 27: 25.
36. Roth E, Steininger R, Winkler S, et al. L-arginine deficiency after liver transplantation as an effect of arginase efflux from the graft. Transplantation 1994; 57: 665.
37. Langle F, Roth E, Steininger R, et al. Arginase release following liver reperfusion: Evidence of hemodynamic action of arginase infusions. Transplantation 1995; 59: 1542.
38. Sorkin L. NMDA evokes an L-NAME sensitive spinal release of glutamate and citrulline. Neuroreport 1993; 4: 497.
39. Sanz-Cameno P, Medina J, Garcia-Buey L, et al. Enhanced intrahepatic inducible nitric oxide synthase expression and nitrotyrosine accumulation in primary biliary cirrhosis and autoimmune hepatitis. J Hepatol 2002; 37: 723.
40. Skinner KA, Crow JP, Skinner HB, et al. Free and protein-associated nitrotyrosine formation following rat liver preservation and transplantation. Arch Biochem Biophys 1997; 342: 282.